MARIO VELASCO, MD
Medical Oncology Physician · DECATUR, IL
Individual Active NPI 1326007782
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 697 | 244,693 | $16,696,654 | $5,496,637 | $4,385,740 |
| 2023 | 534 | 202,005 | $11,776,371 | $3,906,725 | $3,111,551 |
| 2022 | 591 | 228,516 | $11,845,137 | $3,783,057 | $3,021,153 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J1439 | Injection, ferric carboxymaltose, 1 mg | 33,000 | $1 | $1 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 29,750 | $0 | $0 |
| J9299 | Injection, nivolumab, 1 mg | 24,760 | $29 | $23 |
| J9271 | Injection, pembrolizumab, 1 mg | 13,000 | $56 | $45 |
| J0185 | Injection, aprepitant, 1 mg | 6,370 | $2 | $1 |
| J0897 | Injection, denosumab, 1 mg | 5,940 | $26 | $21 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 4,315 | $0 | $0 |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | 3,960 | $25 | $20 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 2,856 | $0 | $0 |
| Q5123 | Injection, rituximab-arrx, biosimilar, (riabni), 10 mg | 2,190 | $39 | $31 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 1,540 | $1 | $1 |
| 96375 | Injection of additional new drug or substance into vein | 1,449 | $14 | $11 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | 036104082 | IL |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Illinois
- NPI 1871580142
- NPI 1992774459
- NPI 1295211373
- NPI 1013273614
- NPI 1225314362
- NPI 1326525114
- NPI 1043283849
- NPI 1891761532
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.